Table 1
Clinical and molecular cytogenetic data of patients with t(11;18) negative gastrointestinal B cell lymphoma
| Patient | Age | Sex | Location | Subtype | Stage | Treatment | Recurrence (month) | FU | Result | Chrom 18 aberration |
|---|---|---|---|---|---|---|---|---|---|---|
| FU, follow up (in months); chrom, chromosome; m, male; f, female; low, low grade marginal zone lymphoma of MALT type; DLBCL+l., diffuse large B cell lymphoma with coexistent low grade marginal zone lymphoma of mucosa associated lymphoid tissue type; DLBCL, diffuse large B cell lymphoma; GE, gastrectomy; CT, chemotherapy; HCE, hemicolectomy; RT, radiotherapy; ER, eradication of Helicobacter pylori; IR, intestinal resection; DWD, dead with disease; DWOD, dead without disease; AWD, alive with disease; AWOD, alive without disease; +18, complete trisomy of chromosome 18; +18q, partial trisomy of chromosome 18; +18/+18q*, mosaic pattern with 33% +18 and 40% +18q. | ||||||||||
| 1 | 80 | m | Stomach | Low | EI 1 | GE | 219 | DWOD | ||
| 2 | 41 | f | Stomach | Low | EI 1 | GE | 115 | AWOD | ||
| 3 | 81 | m | Stomach | Low | EI 1 | GE | 39 | AWOD | ||
| 4 | 61 | m | Stomach | Low | EI 2 | GE+CT | 8 | DWOD | ||
| 5 | 49 | m | Large bowel | Low | EII 1 | HCE+CT+RT | Locally (22) | 22 | DWD | +18q |
| 6 | 66 | f | Stomach | Low | EII 1 | GE | 52 | DWOD | ||
| 7 | 66 | f | Stomach | Low | EII 1 | GE+CT | 55 | AWOD | +18 | |
| 8 | 66 | m | Stomach | Low | EII 1 | GE+CT+ER | 60 | AWOD | ||
| 9 | 79 | m | Stomach | Low | EIV | GE+CT+ER | Locally (10) | 12 | DWD | |
| 10 | 70 | m | Small bowel | Low | EIV | IR+CT | 5 | DWD | ||
| 11 | 51 | m | Stomach | DLBCL+l. | EI | GE | 96 | AWOD | ||
| 12 | 70 | f | Stomach | DLBCL+l. | EII 1 | GE+CT | 177 | AWOD | +18 | |
| 13 | 62 | m | Stomach | DLBCL+l. | EII 1 | GE | 12 | DWOD | ||
| 14 | 71 | f | Stomach | DLBCL+l. | EII 1 | GE+CT | 57 | AWOD | ||
| 15 | 70 | f | Large bowel | DLBCL | EI 2 | HCE | 160 | DWOD | ||
| 16 | 50 | f | Stomach | DLBCL | EI 2 | GE+RT | 290 | DWOD | ||
| 17 | 70 | m | Stomach | DLBCL | EI 2 | GE | 1 | DWD | ||
| 18 | 79 | f | Stomach | DLBCL | EI 2 | GE+CT | Brain (48) | 78 | AWD | |
| 19 | 62 | f | Stomach | DLBCL | EI 2 | GE | 76 | AWOD | ||
| 20 | 74 | m | Stomach | DLBCL | EI 2 | GE+CT | 75 | AWOD | +18 | |
| 21 | 76 | f | Stomach | DLBCL | EI 2 | GE+CT+RT | Locally (72) | 109 | AWOD | |
| 22 | 68 | m | Stomach | DLBCL | EII 1 | GE+CT | 80 | AWOD | ||
| 23 | 82 | m | Stomach | DLBCL | EII 1 | GE | 1 | DWD | +18/+18q* | |
| 24 | 71 | f | Stomach | DLBCL | EII 1 | GE+CT | Locally (6) | 6 | DWD | +18q |
| 25 | 68 | m | Stomach | DLBCL | EII 1 | GE+CT | Locally (10) | 58 | DWD | |
| 26 | 68 | m | Stomach | DLBCL | EII 1 | GE+CT | 80 | AWOD | ||
| 27 | 73 | f | Stomach | DLBCL | EII 1 | GE+CT | 24 | DWOD | ||
| 28 | 76 | m | Stomach+bowel | DLBCL | EII 1 | GE+IR+CT | Locally (11) | 24 | DWD | +18q |
| 29 | 64 | m | Stomach | DLBCL | EII 1 | GE+CT | 24 | DWOD | ||
